Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nancy Ratner

Showing results (71-80 of 147) with videos related to

Pageof 15
Sort By:
Cell Stem Cell|December 2, 2008
Nf1 mutation expands an EGFR-dependent peripheral nerve progenitor that confers neurofibroma tumorigenic potentialJon P Williams, Jianqiang Wu, Gunnar Johansson, et al.
JCI Insight|February 8, 2019
Cxcr3-expressing leukocytes are necessary for neurofibroma formation in miceJonathan S Fletcher, Jianqiang Wu, Walter J Jessen, et al.
Cancer Cell|January 18, 2005
Role for the epidermal growth factor receptor in neurofibromatosis-related peripheral nerve tumorigenesisBenjamin C Ling, Jianqiang Wu, Shyra J Miller, et al.
Pediatric Blood & Cancer|November 9, 2018
Malignant peripheral nerve sheath tumor: Transformation in a patient with neurofibromatosis type 2Laura Agresta, Ralph Salloum, Trent R Hummel, et al.
Molecular and Cellular Biology|March 4, 2003
Brain lipid binding protein in axon-Schwann cell interactions and peripheral nerve tumorigenesisShyra J Miller, Hongzhen Li, Tilat A Rizvi, et al.
Molecular Cancer Therapeutics|May 17, 2008
Effective in vivo targeting of the mammalian target of rapamycin pathway in malignant peripheral nerve sheath tumorsGunnar Johansson, Yonatan Y Mahller, Margaret H Collins, et al.
Life Science Alliance|September 24, 2025
Daytime SHP2 inhibitor dosing, when immune cell numbers are elevated, shrinks neurofibromasNiousha Ahmari, Kwangmin Choi, Jianqiang Wu, et al.
Pediatric Blood & Cancer|April 25, 2015
Preclinical assessments of the MEK inhibitor PD-0325901 in a mouse model of Neurofibromatosis type 1Edwin Jousma, Tilat A Rizvi, Jianqiang Wu, et al.
Cancer Research|August 21, 2020
<i>Cdkn2a</i> Loss in a Model of Neurofibroma Demonstrates Stepwise Tumor Progression to Atypical Neurofibroma and MPNSTKatherine E Chaney, Melissa R Perrino, Leah J Kershner, et al.
Cancer Research|June 16, 2012
PTEN and NF1 inactivation in Schwann cells produces a severe phenotype in the peripheral nervous system that promotes the development and malignant progression of peripheral nerve sheath tumorsVincent W Keng, Eric P Rahrmann, Adrienne L Watson, et al.
Pageof 15

Showing results (71-80 of 147) with videos related to

Sort By:
Pageof 15
Cell Stem Cell|December 2, 2008
Nf1 mutation expands an EGFR-dependent peripheral nerve progenitor that confers neurofibroma tumorigenic potentialJon P Williams, Jianqiang Wu, Gunnar Johansson, et al.
JCI Insight|February 8, 2019
Cxcr3-expressing leukocytes are necessary for neurofibroma formation in miceJonathan S Fletcher, Jianqiang Wu, Walter J Jessen, et al.
Cancer Cell|January 18, 2005
Role for the epidermal growth factor receptor in neurofibromatosis-related peripheral nerve tumorigenesisBenjamin C Ling, Jianqiang Wu, Shyra J Miller, et al.
Pediatric Blood & Cancer|November 9, 2018
Malignant peripheral nerve sheath tumor: Transformation in a patient with neurofibromatosis type 2Laura Agresta, Ralph Salloum, Trent R Hummel, et al.
Molecular and Cellular Biology|March 4, 2003
Brain lipid binding protein in axon-Schwann cell interactions and peripheral nerve tumorigenesisShyra J Miller, Hongzhen Li, Tilat A Rizvi, et al.
Molecular Cancer Therapeutics|May 17, 2008
Effective in vivo targeting of the mammalian target of rapamycin pathway in malignant peripheral nerve sheath tumorsGunnar Johansson, Yonatan Y Mahller, Margaret H Collins, et al.
Life Science Alliance|September 24, 2025
Daytime SHP2 inhibitor dosing, when immune cell numbers are elevated, shrinks neurofibromasNiousha Ahmari, Kwangmin Choi, Jianqiang Wu, et al.
Pediatric Blood & Cancer|April 25, 2015
Preclinical assessments of the MEK inhibitor PD-0325901 in a mouse model of Neurofibromatosis type 1Edwin Jousma, Tilat A Rizvi, Jianqiang Wu, et al.
Cancer Research|August 21, 2020
<i>Cdkn2a</i> Loss in a Model of Neurofibroma Demonstrates Stepwise Tumor Progression to Atypical Neurofibroma and MPNSTKatherine E Chaney, Melissa R Perrino, Leah J Kershner, et al.
Cancer Research|June 16, 2012
PTEN and NF1 inactivation in Schwann cells produces a severe phenotype in the peripheral nervous system that promotes the development and malignant progression of peripheral nerve sheath tumorsVincent W Keng, Eric P Rahrmann, Adrienne L Watson, et al.
Pageof 15